Truveris launches RxDash, a Game-Changer that Allows Instant Price and Plan Design Modeling for Pharmacy Benefits Changes
PBMs, Brokers, Consultants and Plan Administrators Can Get Answers on Price and Member Impact of Proposed Benefits Changes in Seconds Instead of Weeks
NEW YORK, August 20, 2014 – Truveris, a premier pharmacy benefit pricing and analytics company, today announced the launch of RxDashSM, an enterprise platform for pharmacy plan repricing, modeling and reporting. A cutting-edge Software-as-a-Service (SaaS) solution, RxDash enables pharmacy benefit managers (PBMs), health insurers, consulting companies and plan administrators to view in real time the price impact of proposed benefits and price changes.
RxDash helps better meet today’s customer expectations by cutting out the traditional multi-week lag-time for insight into the plan design, pricing and member impact of potential modifications. For PBMs, health insurers and large consulting practices, RxDash calculates in real time how proposed benefit changes increase or decrease costs, illustrates how plan changes affect employees, and helps visualize the impact of step therapy and prior authorizations on plan costs. The robust reporting platform provides ad-hoc and recurring reporting to end clients.
“RxDash eliminates the manual processes that often can take four weeks to complete before employers can understand the impact of a plan design change,” said Bryan Birch, CEO of Truveris. “RxDash immediately calculates the impact of changes so PBMs, brokers, consultants and administrators can make better decisions and ultimately serve their customers more efficiently and effectively. The pricing and reporting platforms are unlike anything available in the market today.”
RxDash is the latest enterprise addition to the Truveris portfolio of tools designed to deliver unprecedented transparency, analytics and reporting to the pharmacy benefit industry, bringing clients new autonomy in making important benefit cost, design and procurement decisions. The fast-growing company’s cloud-based platform currently analyzes nearly 10% of the prescriptions in the U.S., giving Truveris unique insights into the issues and challenges of the $300 billion prescription drug industry in the U.S.
To find out more about this groundbreaking new cloud solution or to view Truveris’ other pharmacy industry products, please visit: www.truveris.com.
Founded in 2009, Truveris enables efficiency, transparency and cost management across the pharmacy benefit process through cloud based, SaaS solutions for PBMs, health insurers, benefit consultants and self-insured companies. Based in New York City, Truveris is funded by Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures and First Round. For more information, visit truveris.com.